Clinical Trials Logo

Clinical Trial Summary

Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.


Clinical Trial Description

Kallmann syndrome is comprised of idiopathic hypogonadotropic hypogonadism and anosmia (inability to smell). Associated phenotypes may include cryptorchidism, microphallus, bone deformations, mirror movements, hearing loss and infertility. Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00623116
Study type Interventional
Source Hospital for Children and Adolescents, Finland
Contact
Status Enrolling by invitation
Phase N/A
Start date December 2007
Completion date December 2025

See also
  Status Clinical Trial Phase
Completed NCT01403532 - Sequential Therapy for Hypogonadotropic Hypogonadism Phase 4
Recruiting NCT03687606 - Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH) Phase 4
Recruiting NCT04463316 - GROWing Up With Rare GENEtic Syndromes
Terminated NCT03118479 - Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH) Phase 1
Active, not recruiting NCT04733274 - Patient and Healthcare Professional Views on Genetic/Genomic Information and Testing
Recruiting NCT01601171 - Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Completed NCT01438034 - Kisspeptin in the Evaluation of Delayed Puberty Phase 1
Recruiting NCT00914823 - Kisspeptin Administration in the Adult Phase 1
Completed NCT01914172 - Health Needs of Patients With Kallmann Syndrome N/A
Completed NCT00392457 - Investigating the Regulation of Reproductive Hormones in Adult Men N/A
Recruiting NCT05971836 - The Molecular Basis of Inherited Reproductive Disorders
Completed NCT00493961 - Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism Phase 1
Completed NCT00494169 - Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
Recruiting NCT02880280 - Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism Phase 4
Terminated NCT00064987 - Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism Phase 2
Completed NCT00392756 - Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS) Phase 1